Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News

5/19/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (April 2020)

Between January and April 2020, the sales of veterinary drugs in the retail market amounted to 6.9 bln RUB (retail prices, VAT included), with the dynamics in monetary terms (rubles) of +0.6%. In comparison with the Q1 dynamics (+20.4%), the dynamics in April seem twice as modest. If calculated in minimum dosage units (MDU), the market volume is 65 bln MDUs, with the dynamics of +2.8%.

5/15/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): Only 17% of Doctors in Russia Undergo Regular Testing for COVID-19

36% of doctors say that no COVID-19 testing is conducted in the hospitals where they work, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

5/7/2020 Database Update: Pharmaceutical Drug Import for Clinical Trials to Russia (March and Q1 2020)

Between January and March 2020, Russia imported 262 thousand units of pharmaceutical drugs for clinical trials (CT), worth 6 bln RUB (customs clearance prices, VAT included). The dynamics in both monetary (rubles) and physical terms (units) are +56%. The number of imported trademarks has risen from 320 to 386. The number of placebo drugs has grown from 109 to 139 trademarks. In physical terms, placebos account for around 30% of the import (against 46% in 2019), while in monetary terms it is 21.7% (nearly the same as in 2019).

5/7/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 63% of Doctors Believe that Incidence of COVID-19 in Russia will not Begin Decreasing until Summer

Only 7% of doctors think that the incidence of coronavirus infection in Russia will start declining as early as mid-May, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors.

4/30/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 71% of Russian Doctors Report Serious Problems with Providing Healthcare Facilities with Personal Protective Equipment (PPE)

Only 8% of Russian doctors say that the healthcare facilities they work in provide all the necessary personal protective equipment, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 17% say that there have been some interruptions in the provision, but the situation is not critical in general.

4/30/2020 Database Update: Pharmaceutical Drug Production in Russia (March and Q1 2020)

Between January and March 2020, Russia manufactured 102.6 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is in monetary terms (rubles) 18 higher than that of the same period in 2019. While the dynamics in monetary terms are promising and not much different from those in late 2019, the dynamics in physical terms (units) are only +0.2%, with 1 bln units manufactured. If calculated in minimum dosage units (MDU), the manufactures volume amounts to 18.6 bln MDUs, with the dynamics of +8.2%.

4/28/2020 Database Update: Veterinary Drug Retail Sales Audit in Russia (March and Q1 2020)

In Q1 2020, the sales of veterinary drugs in the retail market amounted to 4.88 bln RUB (retail prices, VAT included), with the dynamics of +20.4%. The high dynamics could be explained by a number of factors, in particular average price increase and increased demand. The latter could be attributed to atypical weather earlier this year, hence a shift in demand. If calculated in minimum dosage units (MDU), the market volume is 47.4 bln MDUs, with the dynamics of more than +10%.

4/27/2020 Veterinary Vaccine Import to Russia (Q1 2020)

Between January and March 2020, Russia imported 2.1 bln RUB worth of veterinary vaccines (customs clearance prices), which is in monetary terms (rubles) 8.4% lower than that of the same period in 2019. The dynamics in physical terms (units) are as low as -24.8%, or, if calculated in dosages, 13.5%. The import volume amounts to 1.13 mln units, or around 10.16 bln dosages.

4/27/2020 Survey by RNC Pharma and Doktor Na Rabote (Doctor at Work): 53% of Pharmacists Will not Start Online Sales Even after Official Permission

33% of pharmacists say that they consider online drug sales to be unethical, according to an online survey by the RNC Pharma analyst company and the Doktor Na Rabote (Doctor at Work) social media service for doctors. Another 20% noted that they simply would not be able to compete with large online retailers, which makes online development pointless.

4/21/2020 Database Update: Pharmaceutical Drug Import to Russia (March and Q1 2020)

Between January and March 2020, Russia imported 60.4 bln RUB worth of ready-made pharmaceuticals (customs clearance prices, VAT included), which is in monetary terms (rubles) 52% lower than that of the same period in 2019. Russia is still using the volumes imported to Russia last year as part of the preparation for the introduction of the labeling system. However, the dynamics of the in-bulk import are +10%, with the volume of 33.1 bln RUB.